Page 11234..1020..»

COVID-19 Impact on Global and Regional Nanomedicine Industry Production, Sales and Consumption Status and Prospects Professional Market Research…

§ August 12th, 2020 § Filed under Nano Medicine Comments Off on COVID-19 Impact on Global and Regional Nanomedicine Industry Production, Sales and Consumption Status and Prospects Professional Market Research…

The global Nanomedicine market focuses on encompassing major statistical evidence for the Nanomedicine industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions are reported in the study. In addition the Nanomedicine study also shifts its attention with an in-depth competitive landscape, defined growth opportunities, market share coupled with product type and applications, key companies responsible for the production, and utilized strategies are also marked.

This intelligence and 2026 forecasts Nanomedicine industry report further exhibits a pattern of analyzing previous data sources gathered from reliable sources and sets a precedented growth trajectory for the Nanomedicine market. The report also focuses on a comprehensive market revenue streams along with growth patterns, analytics focused on market trends, and the overall volume of the market.

Moreover, the Nanomedicine report describes the market division based on various parameters and attributes that are based on geographical distribution, product types, applications, etc. The market segmentation clarifies further regional distribution for the Nanomedicine market, business trends, potential revenue sources, and upcoming market opportunities.

Download PDF Sample of Nanomedicine Market report @ https://hongchunresearch.com/request-a-sample/2923

Major Players in Nanomedicine market are:, Fraunhofer ICT-IMM, Tecnalia, Bergmannstrost, CIC biomaGUNE, Bracco, Affilogic, LTFN, GIMAC, Endomagnetics, Materials Research Centre, VITO NV, CIBER-BBN, Istec CNR, Carlina technologies, Cristal Therapeutics, ChemConnection, IMDEA, SwedNanoTech, Grupo Praxis, Vicomtech, DTI, Tekniker, Biotechrabbit, Contipro, , Major Regions that plays a vital role in Nanomedicine market are:, North America, Europe, China, Japan, Middle East & Africa, India, South America, Others

Most important types of Nanomedicine products covered in this report are:, Type 1, Type 2, Type 3, Type 4, Type 5

Brief about Nanomedicine Market Report with [emailprotected] https://hongchunresearch.com/report/Nanomedicine-market-2923

Most widely used downstream fields of Nanomedicine market covered in this report are:, Application 1, Application 2, Application 3, Application 4, Application 5

The Nanomedicine market study further highlights the segmentation of the Nanomedicine industry on a global distribution. The report focuses on regions of North America, Europe, Asia, and the Rest of the World in terms of developing business trends, preferred market channels, investment feasibility, long term investments, and environmental analysis. The Nanomedicine report also calls attention to investigate product capacity, product price, profit streams, supply to demand ratio, production and market growth rate, and a projected growth forecast.

In addition, the Nanomedicine market study also covers several factors such as market status, key market trends, growth forecast, and growth opportunities. Furthermore, we analyze the challenges faced by the Nanomedicine market in terms of global and regional basis. The study also encompasses a number of opportunities and emerging trends which are considered by considering their impact on the global scale in acquiring a majority of the market share.

The study encompasses a variety of analytical resources such as SWOT analysis and Porters Five Forces analysis coupled with primary and secondary research methodologies. It covers all the bases surrounding the Nanomedicine industry as it explores the competitive nature of the market complete with a regional analysis.

Some Point of Table of Content:

Chapter One: Nanomedicine Introduction and Market Overview

Chapter Two: Industry Chain Analysis

Chapter Three: Global Nanomedicine Market, by Type

Chapter Four: Nanomedicine Market, by Application

Chapter Five: Global Nanomedicine Production, Value ($) by Region (2014-2019)

Chapter Six: Global Nanomedicine Production, Consumption, Export, Import by Regions (2014-2019)

Chapter Seven: Global Nanomedicine Market Status and SWOT Analysis by Regions

Chapter Eight: Competitive Landscape

Chapter Nine: Global Nanomedicine Market Analysis and Forecast by Type and Application

Chapter Ten: Nanomedicine Market Analysis and Forecast by Region

Chapter Eleven: New Project Feasibility Analysis

Chapter Twelve: Research Finding and Conclusion

Chapter Thirteen: Appendix continued

List of tables List of Tables and Figures

Figure Product Picture of Nanomedicine

Table Product Specification of Nanomedicine

Figure Market Concentration Ratio and Market Maturity Analysis of Nanomedicine

Figure Global Nanomedicine Value ($) and Growth Rate from 2014-2024

Table Different Types of Nanomedicine

Figure Global Nanomedicine Value ($) Segment by Type from 2014-2019

Figure Nanomedicine Type 1 Picture

Figure Nanomedicine Type 2 Picture

Figure Nanomedicine Type 3 Picture

Figure Nanomedicine Type 4 Picture

Figure Nanomedicine Type 5 Picture

Table Different Applications of Nanomedicine

Figure Global Nanomedicine Value ($) Segment by Applications from 2014-2019

Figure Application 1 Picture

Figure Application 2 Picture

Figure Application 3 Picture

Figure Application 4 Picture

Figure Application 5 Picture

Table Research Regions of Nanomedicine

Figure North America Nanomedicine Production Value ($) and Growth Rate (2014-2019)

Figure Europe Nanomedicine Production Value ($) and Growth Rate (2014-2019)

Table China Nanomedicine Production Value ($) and Growth Rate (2014-2019)

Table Japan Nanomedicine Production Value ($) and Growth Rate (2014-2019) continued

About HongChun Research: HongChun Research main aim is to assist our clients in order to give a detailed perspective on the current market trends and build long-lasting connections with our clientele. Our studies are designed to provide solid quantitative facts combined with strategic industrial insights that are acquired from proprietary sources and an in-house model.

Contact Details: Jennifer Gray Manager Global Sales + 852 8170 0792 [emailprotected]

NOTE: Our report does take into account the impact of coronavirus pandemic and dedicates qualitative as well as quantitative sections of information within the report that emphasizes the impact of COVID-19.

As this pandemic is ongoing and leading to dynamic shifts in stocks and businesses worldwide, we take into account the current condition and forecast the market data taking into consideration the micro and macroeconomic factors that will be affected by the pandemic.

More:
COVID-19 Impact on Global and Regional Nanomedicine Industry Production, Sales and Consumption Status and Prospects Professional Market Research...

Read the Rest...

Jennifer.grey The Daily Chronicle – The Daily Chronicle

§ August 12th, 2020 § Filed under Nano Medicine Comments Off on Jennifer.grey The Daily Chronicle – The Daily Chronicle

The global Embedded Telematics Electronic Control Unit (Ecu) market focuses on encompassing major statistical evidence for the Embedded Telematics Electronic Control Unit (Ecu) industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions are reported in the study. In addition the Embedded Telematics Electronic Control Unit (Ecu) study also shifts its attention with an in-depth competitive landscape, defined growth opportunities, market share coupled with product type and applications, key companies responsible for the production, and utilized strategies are also marked.

This intelligence and 2026 forecasts Embedded Telematics Electronic Control Unit (Ecu) industry report further exhibits a pattern of analyzing previous data sources gathered from reliable sources and sets a precedented growth trajectory for the Embedded Telematics Electronic Control Unit (Ecu) market. The report also focuses on a comprehensive market revenue streams along with growth patterns, analytics focused on market trends, and the overall volume of the market.

Moreover, the Embedded Telematics Electronic Control Unit (Ecu) report describes the market division based on various parameters and attributes that are based on geographical distribution, product types, applications, etc. The market segmentation clarifies further regional distribution for the Embedded Telematics Electronic Control Unit (Ecu) market, business trends, potential revenue sources, and upcoming market opportunities.

Download PDF Sample of Embedded Telematics Electronic Control Unit (Ecu) Market report @ https://hongchunresearch.com/request-a-sample/3752

Major Players in Embedded Telematics Electronic Control Unit (Ecu) market are:, Fujitsu Limited (Japan), Pioneer Corporation (Japan), Honda Motor Co., Ltd (Japan), Denso Corporation (Japan), NXP Semiconductors N.V. (Netherlands), Delphi Automotive LLP (UK), Garmin Ltd. (Switzerland), Texas Instruments Incorporated (USA), Audi AG (Germany), Freescale Semiconductor Inc. (USA), Clarion Corporation of America (USA), Ford Motor Company (USA), Infotainment Semiconductor Manufacturers, Infotainment Systems Manufacturers, Harman International (USA), NavTeq Corporation (USA), Volkswagen AG (Germany), Lexus International (Japan), Continental Automotive GmbH (Germany), Toyota Motor Corp. (Japan), Panasonic Corporation (Japan), Robert Bosch GmbH (Germany), TomTom International BV. (The Netherlands), Flextronics International (Singapore), General Motors Corp. (USA), , Major Regions that plays a vital role in Embedded Telematics Electronic Control Unit (Ecu) market are:, North America, Europe, China, Japan, Middle East & Africa, India, South America, Others

Most important types of Embedded Telematics Electronic Control Unit (Ecu) products covered in this report are:, Type 1, Type 2, Type 3, Type 4, Type 5

Brief about Embedded Telematics Electronic Control Unit (Ecu) Market Report with [emailprotected] https://hongchunresearch.com/report/Embedded Telematics Electronic Control Unit (Ecu)-market-3752

Most widely used downstream fields of Embedded Telematics Electronic Control Unit (Ecu) market covered in this report are:, Application 1, Application 2, Application 3, Application 4, Application 5

The Embedded Telematics Electronic Control Unit (Ecu) market study further highlights the segmentation of the Embedded Telematics Electronic Control Unit (Ecu) industry on a global distribution. The report focuses on regions of North America, Europe, Asia, and the Rest of the World in terms of developing business trends, preferred market channels, investment feasibility, long term investments, and environmental analysis. The Embedded Telematics Electronic Control Unit (Ecu) report also calls attention to investigate product capacity, product price, profit streams, supply to demand ratio, production and market growth rate, and a projected growth forecast.

In addition, the Embedded Telematics Electronic Control Unit (Ecu) market study also covers several factors such as market status, key market trends, growth forecast, and growth opportunities. Furthermore, we analyze the challenges faced by the Embedded Telematics Electronic Control Unit (Ecu) market in terms of global and regional basis. The study also encompasses a number of opportunities and emerging trends which are considered by considering their impact on the global scale in acquiring a majority of the market share.

The study encompasses a variety of analytical resources such as SWOT analysis and Porters Five Forces analysis coupled with primary and secondary research methodologies. It covers all the bases surrounding the Embedded Telematics Electronic Control Unit (Ecu) industry as it explores the competitive nature of the market complete with a regional analysis.

Some Point of Table of Content:

Chapter One: Embedded Telematics Electronic Control Unit (Ecu) Introduction and Market Overview

Chapter Two: Industry Chain Analysis

Chapter Three: Global Embedded Telematics Electronic Control Unit (Ecu) Market, by Type

Chapter Four: Embedded Telematics Electronic Control Unit (Ecu) Market, by Application

Chapter Five: Global Embedded Telematics Electronic Control Unit (Ecu) Production, Value ($) by Region (2014-2019)

Chapter Six: Global Embedded Telematics Electronic Control Unit (Ecu) Production, Consumption, Export, Import by Regions (2014-2019)

Chapter Seven: Global Embedded Telematics Electronic Control Unit (Ecu) Market Status and SWOT Analysis by Regions

Chapter Eight: Competitive Landscape

Chapter Nine: Global Embedded Telematics Electronic Control Unit (Ecu) Market Analysis and Forecast by Type and Application

Chapter Ten: Embedded Telematics Electronic Control Unit (Ecu) Market Analysis and Forecast by Region

Chapter Eleven: New Project Feasibility Analysis

Chapter Twelve: Research Finding and Conclusion

Chapter Thirteen: Appendix continued

List of tables List of Tables and Figures

Figure Product Picture of Embedded Telematics Electronic Control Unit (Ecu)

Table Product Specification of Embedded Telematics Electronic Control Unit (Ecu)

Figure Market Concentration Ratio and Market Maturity Analysis of Embedded Telematics Electronic Control Unit (Ecu)

Figure Global Embedded Telematics Electronic Control Unit (Ecu) Value ($) and Growth Rate from 2014-2024

Table Different Types of Embedded Telematics Electronic Control Unit (Ecu)

Figure Global Embedded Telematics Electronic Control Unit (Ecu) Value ($) Segment by Type from 2014-2019

Figure Embedded Telematics Electronic Control Unit (Ecu) Type 1 Picture

Figure Embedded Telematics Electronic Control Unit (Ecu) Type 2 Picture

Figure Embedded Telematics Electronic Control Unit (Ecu) Type 3 Picture

Figure Embedded Telematics Electronic Control Unit (Ecu) Type 4 Picture

Figure Embedded Telematics Electronic Control Unit (Ecu) Type 5 Picture

Table Different Applications of Embedded Telematics Electronic Control Unit (Ecu)

Figure Global Embedded Telematics Electronic Control Unit (Ecu) Value ($) Segment by Applications from 2014-2019

Figure Application 1 Picture

Figure Application 2 Picture

Figure Application 3 Picture

Figure Application 4 Picture

Figure Application 5 Picture

Table Research Regions of Embedded Telematics Electronic Control Unit (Ecu)

Figure North America Embedded Telematics Electronic Control Unit (Ecu) Production Value ($) and Growth Rate (2014-2019)

Figure Europe Embedded Telematics Electronic Control Unit (Ecu) Production Value ($) and Growth Rate (2014-2019)

Table China Embedded Telematics Electronic Control Unit (Ecu) Production Value ($) and Growth Rate (2014-2019)

Table Japan Embedded Telematics Electronic Control Unit (Ecu) Production Value ($) and Growth Rate (2014-2019) continued

About HongChun Research: HongChun Research main aim is to assist our clients in order to give a detailed perspective on the current market trends and build long-lasting connections with our clientele. Our studies are designed to provide solid quantitative facts combined with strategic industrial insights that are acquired from proprietary sources and an in-house model.

Contact Details: Jennifer Gray Manager Global Sales + 852 8170 0792 [emailprotected]

NOTE: Our report does take into account the impact of coronavirus pandemic and dedicates qualitative as well as quantitative sections of information within the report that emphasizes the impact of COVID-19.

As this pandemic is ongoing and leading to dynamic shifts in stocks and businesses worldwide, we take into account the current condition and forecast the market data taking into consideration the micro and macroeconomic factors that will be affected by the pandemic.

Continue reading here:
Jennifer.grey The Daily Chronicle - The Daily Chronicle

Read the Rest...

U of T researchers discover how to get more cancer-fighting nanoparticles to where they’re needed – News@UofT

§ August 12th, 2020 § Filed under Nanotechnology Journal Comments Off on U of T researchers discover how to get more cancer-fighting nanoparticles to where they’re needed – News@UofT

Researchers in the University of Toronto's Faculty of Applied Science & Engineering have discovered a dose threshold that greatly increases the delivery of cancer-fighting drugs into a tumour.

The findings,published recentlyin the journalNature Materials, provide a potentially universal method for gauging nanoparticle dosage and could help advance a new generation of cancer therapy, imaging and diagnostics.

Its a very simple solution adjusting the dosage but the results are very powerful, saysBen Ouyang, an MD/PhD candidate wholed the research under the supervision of ProfessorWarren Chanof U of T's Institute of Biomedical Engineering (BME).

The teams research provides a potential solutionto a drug-delivery problem previously raised by Chan and other researchers four years ago inNature Reviews Materials.

Nanotechnology carriers are used to deliver drugs to cancer sites, which, in turn, can help a patients response to treatment and reduce adverse side effects, including hair loss and vomiting. However, in practice, few injected particles reach the tumour site.

In theNature Reviews Materialspaper, the team surveyed literature from the past decade and found that a median ofonly0.7 per cent of the chemotherapeutic nanoparticlesmake it into a targeted tumour.

The promise of emerging therapeutics is dependent upon our ability to deliver them to the target site, says Chan. We have discovered a new principle of enhancing the delivery process. This could be important for nanotechnology, genome editors, immunotherapyand other technologies.

Chans team saw the liver, which filters the blood, as the biggest barrier to nanoparticle drug delivery. They hypothesized that the liver would have an uptake rate threshold in other words, once the organ became saturated with nanoparticles, it wouldnt be able to keep up with higher doses. Their solution was to manipulate the dose to overwhelm the organs filtering Kupffer cells, which line the liver channels.

The researchers discovered that injecting a baseline of one trillion nanoparticlesin vivowas enough to overwhelm the cells so that they couldnt take up particles quick enough to keep up with the increased doses. The result is a 12 per cent improvement in efficiency in delivering nanoparticles to the tumour.

Theres still lots of work to do to increase the 12 per cent but its a big step from 0.7 per cent, says Ouyang. The researchers also extensively tested whether overwhelming Kupffer cells led to any risk of toxicity in the liver, heart or blood.

We tested gold, silicaand liposomes, says Ouyang. In all of our studies, no matter how high we pushed the dosage, we never saw any signs of toxicity.

The team used thethreshold principle to improve the effectiveness of a clinically used and chemotherapy-loaded nanoparticle called Caelyx. The strategy shrank tumours 60 per cent more when compared to Caelyx on its own with a set dose of the chemotherapy drugdoxorubicin.

Because the researchers solution is a simple one, they hope to see the threshold have a positive impact in current nanoparticle-dosing conventions for human clinical trials. They calculate that the human threshold would be about 1.5 quadrillion nanoparticles.

Theres a simplicity to this method and it reveals that we dont have to redesign the nanoparticles to improve delivery, says Chan. This could overcome a major delivery problem.

The research received support from the Canadian Cancer Society, the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada, among others.

Visit link:

U of T researchers discover how to get more cancer-fighting nanoparticles to where they're needed - News@UofT

Read the Rest...

Integrative Quantum Medicine – The Art Of Energy

§ August 12th, 2020 § Filed under Quantum Medicine Comments Off on Integrative Quantum Medicine – The Art Of Energy

PROPER BALANCE OF ENERGY PROVIDES THE FOUNDATION FOR PERFECT HEALTH!

The body is in a constant state of change, affected by what we eat, our exercise, work and rest habits, daily mental and emotional stress factors as well as changes in the weather!

Most ailments begin from an energy imbalance in the physical, mental, and emotional levels. Just being a responsible member of society can put us in the rat race frame of mind. Stress from imbalances such as these can create energy blockages.

The stress of being overworked and under-appreciated; too much responsibility and too little time; all give and no get will eventually take its toll! Energy blockages from these situations create tension, anxiety, anger or fear and can manifest in many physical forms, such as migraine headaches, indigestion, high blood pressure or ulcers.

Integrative Quantum Medicine, IQM, is a natural non-invasive method of energy medicine that can alter your physiology immediately. What this means is without drugs, medication, needles, herbs, exercises, or physical contact of any kind you are able to release your blockages and return your energy to its balanced state. The result: your headache disappears; the indigestion evaporates; pain diminishes and youre back to normal.

IQM has successfully treated patients with migraine headaches, chronic neck, back, hip and knee pain, carpal tunnel syndrome, arthritis, respiratory ailments, colds, allergies, addictions and weight disorders. Patients who have suffered strokes, seizures and other neurological disorders experience remarkable degrees of recovery with this method. Some patients had suffered for more than 20 years.

IQM is not a belief system, a placebo nor employs the power of suggestion, as illustrated by the successful results with infants and children, as well as animals, correcting physical and behavioral problems. A patients personal beliefs will not affect the outcome of the treatment.

Even more extraordinary than what IQM can do for you is that you can learn to do this for yourself and others within 16 hours!

IQM is the Alternative Healing of the new millennium. And Its Easier Done Than Said!

View original post here:

Integrative Quantum Medicine - The Art Of Energy

Read the Rest...

The quantum brain: What a laser can tell us about the relationship between entangled photons and neurons – ScienceBlog.com

§ August 12th, 2020 § Filed under Quantum Medicine Comments Off on The quantum brain: What a laser can tell us about the relationship between entangled photons and neurons – ScienceBlog.com

Anesthetics have been used for patients undergoing medical procedures for about 175 years, but doctors and scientists have never known exactly how these drugs disrupt consciousness in the brain.

University of Michigan professors Theodore Goodson III and George Mashour are investigating new approaches toward understanding this process. This collaboration, supported by the National Institutes of Health-funded Center of Consciousness, now sets out to further investigate the process in cells.

Goodsons next phase of research will be supported by a grant renewal of $503,551 over the three-year time period from the National Science Foundations divisions of chemistry and physics.

The work of Goodson, a professor of chemistry, applied physics, and macromolecular science and engineering, and Mashour, a professor of anesthesiology and neurosurgery, examines the basic interactions between anesthetic ethers and quantum-entangled photons.

One study, published in Scientific Reports, explored the use of a laser-based quantum mechanical technique to probe anesthetic mechanisms. Bridging the gap between the operating room and the laser laboratory, the two researchers began exploring whether two anesthetic drugs in current clinical use, sevoflurane and isoflurane, could actually interact with entangled photons. Photons that are entangled means that even when a photon is not near its partner, affecting one photon influences the other.

To detect these signals, Goodson and Mashour used spectroscopic and microscopic methods developed by Goodson that use quantum light to examine atomic features that arent visible with classic light. What they found surprised them both: While nonentangled pairs of photons were able to pass through the anesthetic drugs without any interaction, a small fraction of the entangled photons did interact with the anesthetic drugs.

The entangled photon interactions with the anesthetic drugs lead to signals that are so small, theyre not readily detectable by traditional means using classical laser light, Goodson said.

Now, building on other research that showed entangled photons can transmit through brain tissue, Goodson and Mashour will use their quantum optical techniques to test the activity between entangled photons and live glial cells. These studies will be carried out in the presence and in the absence of the anesthetic drugs.

Understanding the biological and chemical processes important to the brain signaling process with this new tool may shed light on new mechanisms of how general anesthetics really work at a fundamental level, they say.

The researchers will use the information they learned while observing the interaction of the entangled photons with the anesthetics to track the signaling process in neurons and possibly within smaller structures in the brain tissue.

In addition to probing the biological and chemical signaling processes in the brain with their quantum optical technique, the collaborative research between Goodson and Mashour may offer the opportunity to investigate other important questions in neuroscience.

For example, this line of research may one day access even deeper questions about where consciousness resides. Modern neuroscience thinks consciousness, or our thought process, emerges from a network of neurons. Investigations with the quantum mechanical tools in the collaboration may allow the tracking of brain signaling activity and, possibly, later connecting this information to the question of consciousness.

Scientists have been theorizing for decades about the connections between consciousness, unconsciousness and quantum physics, said Mashour, who is chair of the Department of Anesthesiology and founded the Center for Consciousness Science. This collaboration with Professor Goodson represents an exciting new direction with a quantum tool to look at these interactions more closely.

Based on this and recent work from the Center for Consciousness Science, U-M is now uniquely poised to test virtually all major theories of consciousness, from the level of subatomic particles to large-scale brain networks. Studying brain signaling with this new quantum tool may help researchers develop new directions in neuroscience, more sophisticated pharmacology that addresses subatomic processes, and photon imaging in biology and medicine.

More information:

See the original post here:

The quantum brain: What a laser can tell us about the relationship between entangled photons and neurons - ScienceBlog.com

Read the Rest...

CBD Nation, Available August 25 On Amazon And Video On Demand, Examines The Highest Levels Of Scientific Research And Medical Evidence Surrounding The…

§ August 12th, 2020 § Filed under Quantum Medicine Comments Off on CBD Nation, Available August 25 On Amazon And Video On Demand, Examines The Highest Levels Of Scientific Research And Medical Evidence Surrounding The…

Explains the film's director and producer David Jakubovic, "Over the course of this project, I came to realize that cannabis is far from a gateway drug; for many, it's actually an exit drug from Pharmaceuticals and Narcotics. And in the U.S. - which has 5% of the world's population consuming 75% of the world's pharmaceuticals - we can no longer afford to be in the dark about the facts. Facts can save lives."

Featuring the world's leading experts in cannabis science and medicine - including acclaimed Israeli scientist Raphael Mechoulam, Ph.D., the 'father of cannabis research' whose 1960s discovery of THC jump started the medical and scientific revolution around cannabis - CBD Nation offers a compelling look at 60 years' worth of published and ongoing research.

"We published our findings thirty-seven years ago: cannabidiol (CBD) blocks epileptic attacks in patients. What happened? Nothing for thirty years," states Raphael Mechoulam, President of The Multidisciplinary Center for Cannabinoid Research at The Hebrew University of Jerusalem."Nothing happened until desperate parents like those in this film did their own research and found out that cannabidiol can help children with epilepsy. But epilepsy is just one of many conditions that we know cannabis medicine can treat. If the world chooses to not look at all of the science, it is not ignorance it's negligence."

Adds longtime cannabis activist, entrepreneur, and restorative justice champion, Steve DeAngelo, who also appears in the film: "CBD Nation brings you the real science that decades of U.S. government sponsored misinformation have hidden from public view. Watch it, and learn why cannabis may just be the most valuable medicine ever discovered by human beings."

Shot in 2018 over the course of six months in the United States, Canada, and Israel, CBD Nation marries a wealth of scientific breakthroughs with first-person narratives, following the emotional stories of patients for whom CBD is a lifesaving medicine.

"CBD Nation tells the authentic origin story of CBD how it took sick kids like Jayden David, Rylie Maedler, and the late Charlotte Figibecoming messengers for this plant in order for mainstream society to acknowledge its potential as medicine," shares Harborside co-founder, cannabis industry consultant and strategic advisor,Andrew DeAngelo. "It is a story about human biology, human rights, and the ultimate victory of truth and science, which could not be more relevant today."

With interviews from more than 30 physicians, clinicians, researchers, and patients, CBD Nation is the first wide release film to dive deep into how the human body has evolved to work with cannabis, providing not only a second chance at life for patients but also a fighting chance for the world's most politicized plant to be accepted for what it is: medicine.

"I hope that U.S. doctors, educators and politicians see this film," says Rylie Maedler, who worked closely with legislators in her home state of Delaware to pass Rylie's Law, granting children with qualifying conditions access to medical cannabis. "Because I'm living proof of the fact that cannabis and CBD have a place in modern medicine."

To learn more about CBD Nation, please visit CBDNationFilm.com.

PRESS CONTACT: [emailprotected]; 646.943.0541

ABOUT MAD MACHINE FILMSLaunched in 2013, Mad Machine Films produces documentary films and commercial content on a wide range of subjects and genres, from cannabis science and quantum physics, to the Vietnam War and concert films. The company was founded by director David Jakubovic, whose most recent credits include directing National Geographic's 2-hour World War 2 special, Heroes of the Sky: the Mighty Eighth Air Force PBS's 1-hour concert film for British pop icon Charli XCX, and the upcoming feature documentary, CBD Nation.

SOURCE Mad Machine Films

https://www.madmachinefilms.com

Read more from the original source:

CBD Nation, Available August 25 On Amazon And Video On Demand, Examines The Highest Levels Of Scientific Research And Medical Evidence Surrounding The...

Read the Rest...

This Is Why Your Asthma Could Be Worse in the Summer, Study Says – MSN Money

§ August 12th, 2020 § Filed under Nano Medicine Comments Off on This Is Why Your Asthma Could Be Worse in the Summer, Study Says – MSN Money

Provided by Best Life

While asthma has long been a common childhood ailment, the number of children developing the condition in recent years is cause for concern. According to the Centers for Disease Control and Prevention (CDC), in 2001, 1 in 14 people had asthmaand as of 2009, that number was up to 1 in 12. Among black children, those rates have risen even more dramaticallyup 50 percent within the same time frame.

Fact: 25 million Americans have asthma. And while this respiratory condition is even more worrisome right now, in the midst of the coronavirus pandemic, it's also troubling because severe attacks could be triggered by the record high temperatures happening across America. New research shows that heat waves and thunderstorms that often occur during the summertime put people with asthma at additional risk.

For the study, which was published in JAMA Internal Medicine on Aug. 10, researchers compared emergency room records due to acute respiratory distress with county-wide atmospheric and lightning data between Jan. 1999 and Dec. 2012. They discovered that there was a spike in hospitalizations52,000 more, to be exactfrom seniors with asthma and chronic obstructive pulmonary disease (COPD) in the three or more days before a major storm.

"We found ER visits rose in the days leading up to the thunderstorm when temperature is rising and the amount of particulate matter in the air begins to rise," study author Anupam Jena, MD, PhD, an associate professor of health care policy at Harvard Medical School, told CNN.

This could be because particulate matterwhich are smaller than dust, dirt, and smoke particlesare dispersed faster and farther when temperatures rise and wind speed picks up before a storm. These microscopic particles can be lodged deep into the lungs, making it extremely difficult to breathe, especially among those with asthma.

"Prior studies suggest that rapid temperature increases can precipitate respiratory problems, and we observed changes in temperature in the days prior to thunderstorms," Jena explained.

RELATED: For more up-to-date information, sign up for our daily newsletter.

Heat and humidity are also known to increase mold growth and seasonal pollen, both of which are common asthma triggers. In fact, the phenomenon known as "thunderstorm asthma" dates back four decades, when asthma attacks were linked to violent thunderstorms in England and Australia.

"If you know a thunderstorm is coming, be mindful just as you would when pollen counts are high, and take a little extra care," Jena said. And for more atmospheric changes that could affect your health, This Rare Weather Event Is About to Make Coronavirus Even Worse.

Video: 1-On-1 With US Surgeon General Dr. Jerome Adams (CBS Minnesota)

1-On-1 With US Surgeon General Dr. Jerome Adams

SHARE

SHARE

TWEET

SHARE

EMAIL

Click to expand

UP NEXT

Go here to see the original:
This Is Why Your Asthma Could Be Worse in the Summer, Study Says - MSN Money

Read the Rest...

Europe Medical Keyboards Medical Mice Market Size Is Rising Tremendously Due To Increasing Need of Healthcare Services Centralization Till 2025 – My…

§ August 12th, 2020 § Filed under Nano Medicine Comments Off on Europe Medical Keyboards Medical Mice Market Size Is Rising Tremendously Due To Increasing Need of Healthcare Services Centralization Till 2025 – My…

Global Medical Keyboards Medical Mice market- Report defines the vital growth factors, opportunities and market segment of top players during the forecast period from 2020 to 2025. The report Medical Keyboards Medical Mice offers a complete market outlook and development rate during the past, present, and the forecast period, with concise study, Medical Keyboards Medical Mice market effectively defines the market value, volume, price trend, and development opportunities. The comprehensive, versatile and up-to-date information on Medical Keyboards Medical Mice market is provided in this report.

The latest research report on Medical Keyboards Medical Mice market encompasses a detailed compilation of this industry, and a creditable overview of its segmentation. In short, the study incorporates a generic overview of the Medical Keyboards Medical Mice market based on its current status and market size, in terms of volume and returns. The study also comprises a summary of important data considering the geographical terrain of the industry as well as the industry players that seem to have achieved a powerful status across the Medical Keyboards Medical Mice market.

Get Sample of this Premium Report @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=121184&RequestType=Sample

Segmentations

Global Medical Keyboards Medical Mice Market: Regional Analysis The report offers in-depth assessment of the growth and other aspects of the Medical Keyboards Medical Mice market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.

Segment by Type:

Keyboard Mice

Segment by application

OEMs Aftermarket

The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.

Global Medical Keyboards Medical Mice Market: Competitive Landscape This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2020.

The major players in the market iKey, Medical Grade, Seal Shield, Active Key, Sterile FLAT, Cleankeys, Keywi, Evo, Man&Machine, Baaske, InduKey, Bytec, Esterline, Wetkeys, Unotron, Athene

Do You Have Any Query Or Specific Requirement @https://brandessenceresearch.biz/Request/Sample?ResearchPostId=121184&RequestType=Methodology

Complete Analysis of the Medical Keyboards Medical Mice Market:

Comprehensive assessable analysis of the industry is provided for the period of 2020-2025 to help investors to capitalize on the essential market opportunities.

The key findings and recommendations highlight vital progressive industry trends in the global Medical Keyboards Medical Mice market, thereby allowing players to improve effective long term policies

A complete analysis of the factors that drive market evolution is provided in the report.

To analyze opportunities in the market for stakeholders by categorizing the high-growth segments of the market

The numerous opportunities in the Medical Keyboards Medical Mice market are also given.

Report Answers Following Questions:

What are the factors driving the growth of the market?

What factors are inhibiting market growth?

What are the future opportunities in the market?

Which are the most dynamic companies and what are their recent developments within the Medical Keyboards Medical Mice Market?

What key developments can be expected in the coming years?

What are the key trends observed in the market?

Full Report from Here @https://brandessenceresearch.biz/ICT-and-Media/Medical-Keyboards-Medical-Mice-Market-Professional-Survey-2019-by-Manufacturers-Regions-Countries-Types-and-Applications-Forecast-to-2024/Summary

TABLE OF CONTENT

1 Report Overview

2 Global Growth Trends

3 Market Share by Key Players

4 Breakdown Data by Type and Application

5 United States

6 Europe

7 China

8 Japan

9 Southeast Asia

10 India

11 Central & South America

12 International Players Profiles

13 Market Forecast 2020-2025

14 Analysts Viewpoints/Conclusions

15 Appendix

About Us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us at [emailprotected]

Blog: https://businessstatsnews.com

Blog: http://www.dailyindustrywatch.com

Blog: https://marketsize.biz

Blog: https://technologyindustrynews.com

Blog: https://marketstatsreport.com

Top Trending Reports:

https://northeast.newschannelnebraska.com/story/42480432/egg-powder-market-share-trends-key-players-analysis-overview-and-competitive-landscape-2020-2025-covid-19-impact-analysis

https://panhandle.newschannelnebraska.com/story/42480071/cosmetic-preservatives-market-size-overview-and-competitive-landscape-and-expected-to-reach-usd-50288-million-by-2025-with-the-cagr-of-653-bmrc

https://midplains.newschannelnebraska.com/story/42480649/agricultural-microbials-market-shares-size-vendors-and-forecasts-analysis-worldwide-expected-to-reach-usd-1188-billion-by-2025-with-a-cagr-of-142

http://www.fox21delmarva.com/story/42465746/commercial-vehicle-market-size-2020-challenges-and-opportunities-trends-and-forecasts-2025-cagr-of-663

https://www.doublet973.com/story/42465746/commercial-vehicle-market-size-2020-challenges-and-opportunities-trends-and-forecasts-2025-cagr-of-663

Excerpt from:
Europe Medical Keyboards Medical Mice Market Size Is Rising Tremendously Due To Increasing Need of Healthcare Services Centralization Till 2025 - My...

Read the Rest...

Sushant Singh Rajput: Here’s what you need to know about the painting that allegedly left the actor shaken – PINKVILLA

§ August 12th, 2020 § Filed under Nano Medicine Comments Off on Sushant Singh Rajput: Here’s what you need to know about the painting that allegedly left the actor shaken – PINKVILLA

Rhea Chakraborty has just revealed details of her and Sushant Singh Rajputs Italy vacation in October 2019. In her statement to officials, Rhea revealed that she saw signs of mental illness for the first time during this trip and a painting Sushant came across during the trip left the late actor shaken.

22

10

120

{{ hasAction('save', 'node', 555901) ? 'Saved' : 'Save' }}

Rhea Chakraborty has claimed that she first saw traces of mental illness in Sushant during their trip to Italy in 2019. Chakraborty recently opened up to officials and shared details of her trip with late boyfriend Sushant Singh Rajput to Italy in October 2019. Rhea revealed that the getaway had quite an impact on Sushant. The actor who had a keen interest in arts and culture was left shaken by a painting, according to Rheas revelations.

Rhea admitted that the painting had a strange effect on Rajput. After coming across the painting, Rhea recalled that Sushant was chanting mantras and looked visibly shaken. While Rhea said she tried consoling Sushant after the incident, it was never the same. Something inside Sushant had been shaken.

The painting titled--Saturn Devouring His Son resides in Museo del Prado, Madrid and is by legendary Spanish artist Francisco Goya. According to the traditional interpretation, it depicts the Greek myth of the Titan Cronus, who, fearing that he would be overthrown by one of his children, ate each one upon their birth. See a picture of the original painting for yourself below:

Coming back to Rheas statement, the VJ and actress also revealed more details on the duos stay in Italy. Chakraborty said that she and Sushant Singh Rajput were staying at a 600-year-old heritage hotel on their vacation and Sushant was blown away by the rich culture of the place. It was previously reported by India Today Television that Sushant's former domestic help Ashok claimed that the late actor's health deteriorated after he returned from the trip.

ALSO READ: Rhea Chakraborty reveals she saw signs of mental illness in Sushant Singh Rajput during their 2019 Europe trip

x Your comment has been submitted to the moderation queue

More:
Sushant Singh Rajput: Here's what you need to know about the painting that allegedly left the actor shaken - PINKVILLA

Read the Rest...

Sports Medicine Market 2020 Size, Share, Regional Growth, Trends, Methods, Applications, Equipment vendors, Business Prospects and Forecast to 2025 -…

§ August 12th, 2020 § Filed under Nano Medicine Comments Off on Sports Medicine Market 2020 Size, Share, Regional Growth, Trends, Methods, Applications, Equipment vendors, Business Prospects and Forecast to 2025 -…

The global Sports Medicine Market Report 2020 was prepared to provide the market landscape and unlimited guidelines for the current market size, market share, driving factors, Trends, progressive growth and the dominant players of the Sports Medicine Market. The report provides top manufacturers, distributors, dealers and dealers with general information about the market. It will help you to understand the product scope, the market overview, the driving force of the market, technological progress, market risk, opportunities and research results.

Our Reports on the Sports Medicine Market for the new Research Areas industrial market offer a holistic analysis, market size and forecast, Trends, growth drivers and challenges as well as a supplier analysis for about 25 suppliers.

Get sample copy of Sports Medicine Market report @ https://www.adroitmarketresearch.com/contacts/request-sample/1578

It provides a knowledge regarding Porters Five Forces including substitutes, potential entrants, buyers, industry competitors, and suppliers with genuine information for understanding the global Sports Medicine market. Furthermore, it offers detailed data of vendors including the profile, specifications of product, sales, applications, annual performance in the industry, investments, acquisitions and mergers, market size, revenue, market share, and more. The Sports Medicine market report delivers an in-depth study of market size, country-level market size, region, segmentation market growth, market share, sales analysis, value chain optimization, market players, the competitive landscape, recent developments, strategic market growth analysis, trade regulations, opportunities analysis, product launches, technological innovations, and area marketplace expanding. The Sports Medicine market reports delivers the knowledge about market competition between vendors through regional segmentation of markets in terms of revenue generation potential, business opportunities, demand & supply over the forecasted period.

Top Leading Key Players are:

Zimmer Biomet, DJO Global, Wright Group N.V., Wright Medical Group N.V. acquired Cartiva in October

Browse the complete report @ https://www.adroitmarketresearch.com/industry-reports/sports-medicine-market

The research report has drafted the report with the offerings of price, production type, acquisition & mergers, Sports Medicine market size, market share, sales analysis, value chain optimization, trade regulations, technological innovations, opportunities analysis, and market players. The report introduces the industrial chain analysis, downstream buyers, and raw material sources along with the accurate insights of Sports Medicine market dynamics. The report also offers a major microscopic view at the market and identifies the footprints of the manufacturers with the help of understanding the global revenue of vendors along with price and sales. The Sports Medicine market delivers quality data and appropriate figures with in terms of region, segmentation, and prominent players. The market report is determined to deliver relevant data about the global keyword market and help readers to find better track to invest in the Sports Medicine industry.

Global Sports Medicine market is segmented based by type, application and region.

Based on Type, the market has been segmented into:

By Product (Body Reconstruction, Body Support & Recovery Products)

Based on application, the market has been segmented into:

By Application (Knee Injuries, Shoulder Injuries, Foot & Ankle Injuries, Hip & Groin Injuries, Elbow & Wrist Injuries, Back & Spine Injuries)

The Sports Medicine market report also covers the regional segments and the market segments which is likely to have an impact on the growth of the market. The report offers an in-depth assessment of the growth and other aspects of the market in key countries including the US, Canada, Mexico, Germany, France, the UK, Russia, Italy, China, Japan, South Korea, India, Australia, Brazil, and Saudi Arabia. The competitive landscape chapter of the global market report provides key information about market players such as company overview, total revenue (financials), market potential, global presence, Sports Medicine market sales and revenue generated, market share, prices, production sites and facilities, products offered, and strategies adopted. This study provides Sports Medicine market sales, revenue and market share for each player covered in this report for a period between 2016 and 2020.

In the final section of the report on Sports Medicine Market, the dashboard view of the companies is provided, to compare the current industrial scenario and their contribution in total Sports Medicine Market. Moreover, it is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment. Report audiences can gain segment-specific manufacturer insights to identify and evaluate key competitors based on the in-depth assessment of their capabilities and success in the Sports Medicine Market.

For Any Query on the Sports Medicine Market: https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/1578

About Us :

Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a markets size, key trends, participants and future outlook of an industry. We intend to become our clients knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Us :

Ryan Johnson Account Manager Global 3131 McKinney Ave Ste 600, Dallas, TX 75204, U.S.A Phone No.: USA: +1 972-362 -8199 / +91 9665341414

See the article here:
Sports Medicine Market 2020 Size, Share, Regional Growth, Trends, Methods, Applications, Equipment vendors, Business Prospects and Forecast to 2025 -...

Read the Rest...

Nanotechnology and Nanomaterials Solutions Driving the Fight Against COVID-19 – PRNewswire

§ August 12th, 2020 § Filed under Nanotechnology Comments Off on Nanotechnology and Nanomaterials Solutions Driving the Fight Against COVID-19 – PRNewswire

DUBLIN, Aug. 11, 2020 /PRNewswire/ -- The "Nanotechnology and Nanomaterials Solutions for COVID-19: Diagnostic Testing, Antiviral and Antimicrobial Coatings and Surfaces, Air-Borne Filtration, Facemasks, PPE, Drug Delivery and Therapeutics" report has been added to ResearchAndMarkets.com's offering.

Nanotechnology and nanomaterials can significantly address the many clinical and public healthcare challenges that have arisen from the coronavirus pandemic. This analysis examines in detail how nanotechnology and nanomaterials can help in the fight against this pandemic disease, and ongoing mitigation strategies. Nano-based products are currently being developed and deployed for the containment, diagnosis, and treatment of Covid-19.

Nanotechnology and nanomaterials promise:

Report contents include:

Key Topics Covered:

1 RESEARCH SCOPE AND METHODOLOGY 1.1 Report scope 1.2 Research methodology

2 INTRODUCTION

3 DIAGNOSTIC TESTING 3.1 Nanotechnology and nanomaterials solutions 3.2 Market revenues 3.3 Companies 3.4 Academic research

4 ANTIVIRAL AND ANTIMICROBIAL COATINGS AND SURFACES 4.1 Nanotechnology and nanomaterials solutions 4.2 Market revenues 4.3 Companies 4.4 Academic research

5 AIR-BORNE VIRUS FILTRATION 5.1 Nanotechnology and nanomaterials solutions 5.2 Market revenues 5.3 Companies 5.4 Academic research

6 FACEMASKS AND OTHER PPE 6.1 Nanotechnology and nanomaterials solutions (Polymer nanofibers, Nanocellulose, Nanosilver, Graphene) 6.2 Market revenues 6.3 Companies 6.4 Academic research

7 DRUG DELIVERY AND THERAPEUTICS 7.1 Nanotechnology and nanomaterials solutions 7.2 Market revenues 7.3 Companies 7.4 Academic research

8 REFERENCES

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/cdurs3

About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

Originally posted here:

Nanotechnology and Nanomaterials Solutions Driving the Fight Against COVID-19 - PRNewswire

Read the Rest...

Opportunities in the World Nanotechnology Market to 2025 – Application of Nanotechnology in Wastewater Treatment and Enhanced Renewable Energy Driving…

§ August 12th, 2020 § Filed under Nanotechnology Comments Off on Opportunities in the World Nanotechnology Market to 2025 – Application of Nanotechnology in Wastewater Treatment and Enhanced Renewable Energy Driving…

August 12, 2020 06:53 ET | Source: Research and Markets

Dublin, Aug. 12, 2020 (GLOBE NEWSWIRE) -- The "Nanotechnology Market - Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

Nanotechnology includes fields of science as diverse as molecular nanotechnology, surface science, organic chemistry, molecular biology, semiconductor physics, energy storage, micro-fabrication, and molecular engineering. The technology finds applications in a gamut of industries such as medicine & healthcare, environment, ICT, energy, nano-EHS, and others. A key application of nanotechnology is found in electronics and semiconductor products segment, which is estimated to grow at a substantial CAGR of 15.01% through to 2025.

Nanotechnology Market Growth Drivers:

Nanotechnology Market Trends:

Nanotechnology Market Challenges: The most challenging aspect in the nanotechnology market is scalability of production. Even though nanomaterials impart an outstanding functional performance in the laboratory or prototype stage, the scalability factor is dwarfing the nanotechnology market size. Hence, some of the most propitious applications are in the R&D stage. However, in the future, significant developments are expected in the application of nanotechnology with a profitable commercialization in the automotive, aerospace, and sporting goods industry. Furthermore, the technology will help in effective treatment of cancer which will support the vendors in the nanotechnology market.

Nanotechnology Market Research Scope: The base year of the study is 2020, with forecasts up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the nanotechnology market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The nanotechnology market research report also analyses the application of the same in various industries by product type that includes nano composites, nano devices, nano tools, nano materials, and others.

Key Topics Covered:

1. Nanotechnology Market - Overview 2. Nanotechnology Market - Executive summary

3. Nanotechnology Market

4. Nanotechnology Market Forces

5. Nanotechnology Market -Strategic analysis 5.1. Value chain analysis 5.2. Opportunities analysis 5.3. Product life cycle 5.4. Suppliers and distributors Market Share

6. Nanotechnology Market - By Type (Market Size -$Million / $Billion) 6.1. Market Size and Market Share Analysis 6.2. Application Revenue and Trend Research 6.3. Product Segment Analysis

7. Nanotechnology Market - By Applications (Market Size -$Million / $Billion) 7.1. Introduction 7.2. Medicine and Healthcare Diagnosis 7.3. Environment 7.4. Energy 7.5. Information and Communication Technologies 7.6. Nano-EHS

8. Nanotechnology - By End Use Industry(Market Size -$Million / $Billion) 8.1. Segment type Size and Market Share Analysis 8.2. Application Revenue and Trends by type of Application 8.3. Application Segment Analysis by Type

9. Nanotechnology - By Geography (Market Size -$Million / $Billion) 9.1. Nanotechnology Market - North America Segment Research 9.2. North America Market Research (Million / $Billion) 9.3. Nanotechnology - South America Segment Research 9.4. South America Market Research (Market Size -$Million / $Billion) 9.5. Nanotechnology - Europe Segment Research 9.6. Europe Market Research (Market Size -$Million / $Billion) 9.7. Nanotechnology - APAC Segment Research 9.8. APAC Market Research (Market Size -$Million / $Billion)

10. Nanotechnology Market - Entropy 10.1. New product launches 10.2. M&A's, collaborations, JVs and partnerships

11. Nanotechnology Market Company Analysis 11.1. Market Share, Company Revenue, Products, M&A, Developments 11.2. include Nanosys 11.3. QD Vision 11.4. Arkema 11.5. 10Angstroms 11.6. 10x MicroStructures 11.7. 10x Technology Inc 11.8. 3M 3rd Millennium Inc 11.9. 3rdTech Inc

For more information about this report visit https://www.researchandmarkets.com/r/r2psqq

About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Continued here:

Opportunities in the World Nanotechnology Market to 2025 - Application of Nanotechnology in Wastewater Treatment and Enhanced Renewable Energy Driving...

Read the Rest...

Futuristic Growth in Nanotechnology in Medical Applications Market 2020 Report Outlining the Current State of the Market by 2020-2027 Along with Key…

§ August 12th, 2020 § Filed under Nanotechnology Comments Off on Futuristic Growth in Nanotechnology in Medical Applications Market 2020 Report Outlining the Current State of the Market by 2020-2027 Along with Key…

Nanotechnology in Medical Applications Market is a comprehensive report on the global market provides in-depth insight into the industry covering all the important parameters and analyzes that provide qualitative insight into the factors that affect Global Nanotechnology in Medical Applications Market growth. Includes all regions and countries in the world that show regional development status including market size.

Global Nanotechnology in Medical Applications Market research report has published by QY Reports and it is an effective data source for the readers. It offers widespread information on the Global Nanotechnology in Medical Applications Market. The purpose of this study is to define the overview of the global market with respect to market size, shares, sales patterns, and pricing structures. Primary and secondary research refer collect the desired data of the target market.

Ask for Sample Copy of This Report: https://www.qyreports.com/request-sample/?report-id=65147

Top Key Players Included in This Report:

Stryker Corporation (U.S.),3M Company (U.S.),St. Jude Medical Inc.(U.S.),PerkinElmer Inc. (U.S.).

The research objectives of this report are as follows:

Get Discount on This Report: https://www.qyreports.com/ask-for-discount/?report-id=65147

The report also summarized the high revenue generated with market facts and figures across regions such as North America, Japan, Europe, Asia and India. We focus on the key issues needed to have a positive impact on the market, such as policy, international trade, and speculation and supply demand in the Global Nanotechnology in Medical Applications Market.

This market research report on the Global Nanotechnology in Medical Applications Market is a comprehensive study of industry-specific frameworks, industry-strength drivers and manacles. Over the next seven years, we will provide market forecasts for the future. The study also provides markets for sectors such as end users, industries and size.

The report also covers in-depth explanations, competitive scenarios, and a broad product portfolio with a broad product portfolio of key players in Global Nanotechnology in Medical Applications Market and SWOT analysis adopted by competitors. This report provides Porter analysis, PESTEL analysis and market appeal to help you better understand macro and microscopic market scenarios.

If You Have Any Query, Ask Our Experts: https://www.qyreports.com/enquiry-before-buying/?report-id=65147

Table of Contents:

Chapter 1: Global Nanotechnology in Medical Applications Market Overview Chapter 2: Global Economic Impact on Industry Chapter 3: Market Competition by Manufacturers Chapter 4: Production, Revenue (Value) by Region Chapter 5: Supply (Production), Consumption, Export, Import by Regions Chapter 6: Production, Revenue (Value), Price Trend by Type Chapter 7: Global Nanotechnology in Medical Applications Market Analysis by Application Chapter 8: Manufacturing Cost Analysis Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 10: Marketing Strategy Analysis, Distributors/Traders Chapter 11: Market Effect Factors Analysis Chapter 12: Global Nanotechnology in Medical Applications Market Forecast

About Us Qyreports:

We at, Qyreports, a leading market research report published accommodate more than 4,000 celebrated clients worldwide putting them at advantage in todays competitive world with our understanding of research. Our list of customers includes prestigious Chinese companies, multinational companies, SMEs and private equity firms whom we have helped grow and sustain with our fact-based research. Our business study covers a market size of over 30 industries offering unfailing insights into the analysis to reimagine your business. We specialize in forecasts needed for investing in a new project, to revolutionize your business, to become more customer centric and improve the quality of output.

Contact:

QYReports

Jones John

(Sales Manager)

204, Professional Centre,

7950 NW 53rd Street, Miami, Florida 33166

+1-510-560-6005

[emailprotected]

http://www.qyreports.com

Originally posted here:

Futuristic Growth in Nanotechnology in Medical Applications Market 2020 Report Outlining the Current State of the Market by 2020-2027 Along with Key...

Read the Rest...

Avalon GloboCare expands and files two patents for developing a decoy cytokine receptor-based filter system to treat cytokine storms" – Proactive…

§ August 12th, 2020 § Filed under Nanotechnology Comments Off on Avalon GloboCare expands and files two patents for developing a decoy cytokine receptor-based filter system to treat cytokine storms" – Proactive…

Patients infected with the SARS-CoV-2 virus that causes the coronavirus COVID-19 are susceptible to developing cytokine storms, which occur when the immune system suddenly produces high levels of inflammatory proteins called cytokines that concentrate in the blood

. () announced that it has expanded and filed two provisional patents with the US Patent and Trademark Office outlining compositions and methods of developing a decoy cytokine receptor-based filter system to treat cytokine storms.

The clinical-stage global developer of cell-based technologies and therapeutics said these provisional patent applications are direct results of recent advancements related to Avalons AVA-Trap therapeutic program.

The technology utilizes cytokine receptorFc-fusion proteins to potentially serve as an antibody-like decoy to dampen the excessive cytokine release that occurs during hyper-activation of the immune systema life-threatening condition called cytokine storm that can cause multi-organ failure and death.

Patients infected with the SARS-CoV-2 virus that causes the coronavirus COVID-19 are susceptible to developing cytokine storms, which occur when the immune system suddenly produces high levels of inflammatory proteins called cytokines that concentrate in the blood.

The extracorporeal hemo-purifier device is designed to provide potential treatment for patients experiencing cytokine storms induced by COVID-19, hepatitis, HIV, influenza, graft-versus-host disease, and cytokine release syndrome associated with CAR-T cell therapy.

The company said the expanded patent application was jointly filed with Professor Shuguang Zhang of the Massachusetts Institute of Technology (MIT) Media Lab, and Professor Uwe Sleytr, a full member of the Austrian Academy of Sciences and pioneer of applied surface layer (S-layer) nanotechnology.

The application combines Avalons AVA-Trap program with two innovative technologies. The first is the QTY code protein design platform, which was developed together with Professor Shuguang Zhangs laboratory at MIT. This technology platform can turn water-insoluble proteins that normally reside within cellular membranesand that can be difficult to work within the laboratoryinto water-soluble proteins that can be used in many clinical applications.

The second technology is applied S-layer nanotechnology, based on the repetitive protein structures that make up the outer surface of microbial cells. Coating of S-layers on solid surfaces can greatly enhance the binding orientation and efficiency of targeted ligand proteins that are directed to bind to, and capture, molecules of choice in the blood.

Together, Avalon is developing these unique technologies to advance an extracorporeal hemodialysis and hemo-purification device consisting of membrane protein receptors for specific cytokines coated onto an S-layer-based matrix that can be used to specifically filter out cytokines responsible for a cytokine storms in patients experiencing this immune system attack on the body, including patients with COVID-19.

While non-specific blood filtration systems exist, the clinical AVA-Trap blood filtration system would specifically target cytokine storm-causing proteins, allowing the detection and recovery of cytokinesand serving as a potential clinical therapy as well as a diagnostic tool. Importantly, it is the Companys goal to develop a filtration system that can be customized to trap only specific molecules.

In a statement, David Jin, president and chief executive officer of Avalon said: We are grateful for our strong scientific partnerships that enabled the rapid speed with which we are developing this novel clinical tool.

This medical device holds enormous promise as it directly addresses a leading cause of mortality for patients with illnesses that make them vulnerable to the damaging effects of a cytokine storm, he added.

Avalon GloboCare is a clinical-stage, vertically-integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics.

Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth and development, as well as competitiveness in healthcare and CellTech industry markets.

Through its subsidiary structure with unique integration of verticals from innovative R&D to automated bioproduction and accelerated clinical development, Avalon is establishing a leading role in the fields of cellular immunotherapy (including CAR-T/NK), exosome technology (ACTEX), and regenerative therapeutics.

Contact the author at[emailprotected]

Excerpt from:

Avalon GloboCare expands and files two patents for developing a decoy cytokine receptor-based filter system to treat cytokine storms" - Proactive...

Read the Rest...

Using Violin Synchronization to Learn About Better Networking – Stony Brook News

§ August 12th, 2020 § Filed under Nanotechnology Comments Off on Using Violin Synchronization to Learn About Better Networking – Stony Brook News

Human networking involves every field and includes small groups of people to large, coordinated systems working together toward a goal be it traffic management in an urban area, economic systems or epidemic control. A new study published in Nature Communications suggests by using a model of violin synchronization in a network of violin players, there are ways to drown out distractions and miscommunications, which could be used as a model for human networks in society.

Titled The Synchronization of Complex Human Networks, the study was conceived by Elad Shniderman, a graduate student in the Department of Music in the College of Arts and Sciences at Stony Brook University, and scientist Moti Fridman, PhD, at the Institute of Nanotechnology and Advanced Materials at Bar-llan University. He co-authored the paper with Daniel Weymouth, PhD, associate professor of Composition and Theory in the Department of Music and scientists at Bar-llan and the Weizmann Institute of Science in Israel. The collaboration was initiated at the Fetter Museum of Nanoscience and Art.

The research team devised an experiment involving 16 violinists with electric violins connected to a computer system. Each violinist had sound-canceling headphones, hearing only the sound received from the computer. All violinists played a simple repeating musical phrase and tried to synchronize with other violinists according to what they heard in their headphones.

According to Shniderman, Weymouth and their fellow authors: Research on network links or coupling has focused predominantly on all-to-do coupling, whereas current social networks and human interactions are often based on complex coupling configurations.

This study of synchronization between violin players in complex networks with full control over network connectivity, coupling strength and delay, revealed that players can tune their playing period and delete connections by ignoring frustrating signals to find a stable solution. These controlled and new degrees of freedom enable new strategies and yield better solutions potentially applicable for other human networking models.

Society in its complexity is recognizing how human networks affect a broad range of crucial issues, including economic inequality, stock market crashes, political polarization and the spread of disease, said Weymouth. We believe there are a lot of important, real-world applications to the results of this experiment and ongoing work.

To view how the experiment is carried out and for additional perspective from Shniderman, see this video:

Sync Variations from Elad Shniderman on Vimeo.

Read more:

Using Violin Synchronization to Learn About Better Networking - Stony Brook News

Read the Rest...

Food Nanotechnology Market Application, Investment Type, and Region Analysis by 2020-2026 – eRealty Express

§ August 12th, 2020 § Filed under Nanotechnology Comments Off on Food Nanotechnology Market Application, Investment Type, and Region Analysis by 2020-2026 – eRealty Express

The Food Nanotechnology Marketalong with the global markets has been evolving, the potential for Food Nanotechnology market has seen a great deal of uproar both in demand and in revenue, technologies, mergers and acquisitions grow to be more and more important and vital to the growth of the Food Nanotechnology marketplace, and here in this report, we provide you with the most up to date data along with forecast, precise statistics which can place you right amongst the top players in the Food Nanotechnology market.

Top Companies covering This Report are: Aquanova Blue California Frutarom Industries Southwest Research Institute

Get Sample PDF Brochure @ https://www.reportsintellect.com/sample-request/1236697

The following report discusses in detail the factors essential and crucial to the growth of the Food Nanotechnology market. These factors include risks of the market calculated with the history of the Food Nanotechnology market over the past years, acquisitions, mergers, new trends, assessment of the new technologies and their implementation, and a much more in-depth look at the very crucial factors that drive the growth of the market internationally.

Key Product Type Nano Materials Nano Tools Nano Devices

Market by Application Food Packaging Food Processing Food Testing Others

Discount PDF Brochure @ https://www.reportsintellect.com/discount-request/1236697

Market Segment by Regions, regional analysis covers

North America (United States, Canada, Mexico)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia)

South America (Brazil, Argentina, Colombia, etc.)

Europe, Middle East & Africa (Germany, France, UK, Russia and Italy, Saudi Arabia, UAE, Egypt, Nigeria, South Africa)

Table of Content:

1 Market Overview 2 Companys Profiles 3 Sales, Revenue and Market Share by companies 4 Global Market Analysis by Regions 5 North America by Country 6 Europe by Country 7 Asia-Pacific by Regions 8 South America by Country 9 Middle East & Africa by Countries 10 Market Segment by Type 11 Global Food Nanotechnology Market Segment by Application 12 Market Forecast 13 Sales Channel, Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix

Reasons to buy:

About Us:

Reports Intellect is your one-stop solution for everything related to market research and market intelligence. We understand the importance of market intelligence and its need in todays competitive world.

Our professional team works hard to fetch the most authentic research reports backed with impeccable data figures which guarantee outstanding results every time for you. So whether it is the latest report from the researchers or a custom requirement, our team is here to help you in the best possible way.

Contact us:

[emailprotected] Phone No: + 1-706-996-2486 US Address: 225 Peachtree Street NE, Suite 400, Atlanta, GA 30303

View post:

Food Nanotechnology Market Application, Investment Type, and Region Analysis by 2020-2026 - eRealty Express

Read the Rest...

The first Virtual Microscope of the human brain, developed by Darmiyan, accurately measures Alzheimer’s-related abnormalities – PRNewswire

§ August 12th, 2020 § Filed under Nano Medicine Comments Off on The first Virtual Microscope of the human brain, developed by Darmiyan, accurately measures Alzheimer’s-related abnormalities – PRNewswire

"Darmiyan's AI, machine learning algorithm using unique MRI microscopic voxel analysis with macroscopic input has generated a very sensitive and specific five year prognosis for patients presenting with amnestic MCI," noted Jamshid Ghajar, MD, PhD, FACS, Moghadam Family Director of Stanford Medicine Brain Performance Center. "This technology has high test-retest reliability and can be applied to any clinical grade MRI which is a very useful clinical tool to assist doctors advising patients with early memory complaints."

"Darmiyan's vision excited me because it offers a biologically-based, objective, and sensitive method for detecting changes in the brain that may first show up as subtle changes in memory and cognition and later, as neurodegenerative disease progresses, lead to more serious cognitive and functional deficits. The promise of a new tool that can give patients and their doctors a head start in planning for and possibly even heading off the advance of dementia is exactly what is needed right now, as the aging population grows larger. With the successful conclusion of this project, Darmiyan moves a step closer to delivering on this promise," said Bradley Buchsbaum, PhD, Cognitive Neuroscience Associate Professor at University of Toronto, Senior Scientist at Baycrest Institute & Rotman Research Institute, and the Principal Investigator of the Canadian arm of Darmiyan's validation project.

Validating BrainSeeon Both Clinical-grade and Research-grade Data

The current study showed that BrainSee performs with as high accuracy on clinical-grade data (from patients who present to clinics and hospitals) as it had previously performed on research-grade data (from patients who volunteer for research or clinical trials). This makes BrainSee the first cutting-edge solution that can be easily integrated in any community clinical setting around the world, not just the high-end academic institutions.

A blind retrospective analysis was previously conducted on 411 amnestic mild cognitive impairment (aMCI) patients with research-grade input data (MRI: 3D T1, T2, DTI; plus MMSE & CDR) reporting 90+% performance accuracy. In the current third-party validation study, external investigators blind-tested BrainSee on 107 new patients with clinical-grade input data (routine clinical T1, T2, DWI; plus MMSE & estimated CDR from clinician notes).

While all 107 patients held the same clinical diagnosis label of aMCI, BrainSee visualized and quantified microstructural differences that existed in each patient's brain, and predicted if they would convert to Alzheimer's dementia within 5 years (converter) or stay stable/ improve (non-converter). Investigators compared BrainSee's predictions against the actual clinical diagnosis five years later. The overall predictive accuracy of BrainSee was reported as 91% (Sensitivity 90%, Specificity 92%)."Such an accurate and non-invasive prognostic tool is non-existent in the market today," noted the US investigators.

The current study also included a separate analysis for evaluating BrainSee's test-retest reliability on 84 additional aMCI patients who were recruited to get two brain MRI scans on the same day: one clinical-grade and one research-grade. The test-retest reliability (consistency) of BrainSee was reported very high, with a correlation coefficient of 99.5%.

With this external validation data, the total number of aMCI patients tested by BrainSee has reached 602.

Novel Technological Advantages

"While reading brain PET scans at Stanford & NYU hospitals as a radiologist, I imagined the day when we could help clinicians visualize and evaluate brain health more comprehensively and objectively while posing less discomfort to patients. That day has come now and Darmiyan's BrainSee technology can finally bring clarity to the field of Alzheimer's through visualizing brain tissue microstructure for doctors. Darmiyan's Virtual Microscope technology unlocks the enormous informative potential of the currently underutilized brain MRI scans," said Darmiyan's Chief Medical and Technology Officer, Kaveh Vejdani, MD. "The huge advantage of MRI modality over PET is that it is safer (no radiation exposure), faster, more cost-efficient, non-invasive (does not require radiotracer injection), and much more widely available throughout the world."

According to Dr. Michael G. Harrington, FRCP, Scientific Director of Neuroscience, HMRI, "Objective measures such as Darmiyan's BrainSee that can predict cognitive decline are strongly needed to recognize and monitor potential therapies."

Meeting Today's Clinical Needs

Alexandra Papaioannou, MD, Executive Director, and George Ioannidis, PhD, Associate Scientific Director of GERAS Centre at HHS (both Professors of Medicine at McMaster University) noted that Darmiyan's non-invasive technology "could result in an important development in the Alzheimer's field" as it has "performed well in predicting disease progression" and can "improve clinicians' workflow and how patients are monitored."

David J. Mikulis, MD, Professor and Director of the JDMI (Joint Department of Medical Imaging) Functional Neuroimaging Research Lab, UHN, noted: "I was impressed by the potential of this breakthrough technology. All study investigators are optimistic that Darmiyan's solution will be successful providing a much needed predictor of disease progression. It may therefore fill a significant diagnostic gap highly valued by patients, clinicians, and clinical researchers."

"With the great help of our clinical trials sites in the US and Canada, we demonstrated that BrainSee can well integrate in the clinical workflow without imposing any limitations, such as specific MRI protocol, in the process of monitoring MCI patients," said Darmiyan's CEO Padideh Kamali-Zare, PhD. "These data support our vision to make BrainSee readily accessible for all people worldwide addressing the dire need for accurate diagnosis of Alzheimer's disease and prognosis of mild cognitive impairment in clinics and clinical trials. Localizing and quantifying early signs of brain cell distortion, in a way that is agnostic to specific protein-based biomarkers such as amyloid or tau, is key to understanding the disease pathology early on in its process and providing personalized treatments suitable for each Alzheimer's patient in the future."

About Darmiyan, Inc.

Darmiyan(based in San Francisco, CA) was incorporated in September 2016 and backed by Y-Combinator (YC) in Summer 2017. The Company has won numerous awards and recognitions including the TEDMED Hive Innovator in 2018 and CABHI Innovation Award in 2019. Darmiyan's most recent funding in 2020 was led by the global pharma giant Eisai with participation of YC and IT-Farm.

SOURCE Darmiyan

Home

Read more from the original source:
The first Virtual Microscope of the human brain, developed by Darmiyan, accurately measures Alzheimer's-related abnormalities - PRNewswire

Read the Rest...

Want healthier, cleaner skin? The answer could be to stop showering – Telegraph.co.uk

§ August 12th, 2020 § Filed under Nano Medicine Comments Off on Want healthier, cleaner skin? The answer could be to stop showering – Telegraph.co.uk

Since the 2016 experiment, hes begun showering again, though far less frequently than before and in a way that would likely seem unusual to the average Brit. I take short, quick showers that arent hot, he explains and uses nothing but water. It gives me a rinse, makes my hair lay down, and makes me feel like theres some divide between night and day in this pandemic time, especially. He also brushes his teeth I dont want them to rot, he points out and uses hand soap. I wash my hands because I dont want to have diseases, he says. Im deliberate about why Im doing what Im doing, and I cut out the things Ive just been doing unquestionably.

Things many of us have been doing unquestionably may mean a step away from teeth whitening kits. Teeth whitening is a great example, he says. Its very much social, and about beauty. But it doesnt actually have to do with hygiene, and it doesnt mean your teeth arent free of bacteria and you dont have an oral infection. But as with the rise and changing face of soap during the Industrial Revolution, so the rise of kits to bleach the stains from our teeth mimics the past, intertwining health and beauty together inexorably.

In the book, Hamblin explains how the use of soap was a social signifier. There was great social value in knowing you werent part of the people living next to the open sewage piles that were in London and elsewhere, he says. You were part of the washed class because you could afford soap and water. The product was expensive, and it demonstrated that you were a cut above the rest. But the Industrial Revolution changed that: now, soap could be made cheaply en masse, and was available to most people to use as a way of maintaining their hygiene and safety.

Soap manufacturers then pivoted. They needed a way to continue to sell that class of beauty, says Hamblin. They produced more expensive soaps, only for luxury purposes. Chemically it was almost an identical product, but with two different consumer entry points and supposed additional value. And so theyve continued today in the same vein: cheaper, bulk-buy soaps lack the colouring and scent that more expensive ones do. Were also bombarded with messages about added ingredients that transform the humble bar of soap into something luxe and with that comes added cost.

Showers for Hamblin have started to serve a different purpose to most people: rather than being to keep clean, they signify the start of his day. This is an odd time, and at times like this, it becomes important to do things that ground you, he explains. Whether its making your bed, eating at rigid meal times or dressing up for working from home, certain rituals are important in keeping us grounded. These markers are important to us to maintain the rhythms of how our minds and bodies are meant to function, he says.

Where he wont compromise on cleanliness is in hand washing. Hands, face, space may be the phrase of the moment, uttered by the prime minister every other breath, but the importance of soap and water isnt lost on the doctor. Its the one instance where he thinks the line between health and beauty is becoming more distinct and its thanks to the coronavirus.

The moment right now with the pandemic is very important, he says. Humans are starting to ask: What is the necessary, important hygienic practice to prevent the spread of disease and what are we doing for all the other reasons? Hamblin believes that the books release comes at a good time because the public are more receptive to rethinking their beliefs. Moments of crisis like this tend to have the effect of resetting peoples value systems, he says. Most people are probably insecure about their health, their financial status, their social systems. Its moments like this where people take stock of what really matters.

Read the original here:
Want healthier, cleaner skin? The answer could be to stop showering - Telegraph.co.uk

Read the Rest...

Novartis : receives EC approval for new Xolair indication to treat severe chronic rhinosinusitis with nasal polyps – Marketscreener.com

§ August 12th, 2020 § Filed under Nano Medicine Comments Off on Novartis : receives EC approval for new Xolair indication to treat severe chronic rhinosinusitis with nasal polyps – Marketscreener.com

Basel, August 6, 2020 - Novartis today announced that the European Commission (EC) has approved Xolair (omalizumab) as an add-on therapy with intranasal corticosteroids (INC) for the treatment of adults (18 years and above) with severe chronic rhinosinusitis with nasal polyps (CRSwNP) for whom therapy with INC does not provide adequate disease control1. Phase III studies have shown that Xolair reduces nasal polyp size (defined by Nasal Polyp Score; NPS) and improves symptoms and quality of life in patients with CRSwNP5. Xolair is the first treatment for CRSwNP specifically targeting and blocking immunoglobulin E (IgE), a key driver in the inflammatory pathway of this disease.

'People with chronic rhinosinusitis with nasal polyps can experience significant quality of life impairment as a result of their symptoms. The symptoms include long-term nasal congestion and blockage, sleep disruption and loss of smell and taste,' said Lars Ingemann, Academic Director, EUFOREA*. 'The EUFOREA* patient advisory board welcomes today's approval, which will provide an additional treatment option to patients with severe chronic rhinosinusitis with nasal polyps.'

*EUFOREA: The European Forum for Research and Education in Allergy and Airway Diseases

About Xolair (omalizumab) Xolair is the only approved anti-immunoglobulin E (IgE) antibody treatment specifically designed to target and block IgE. By reducing free IgE, down-regulating high-affinity IgE receptors and limiting mast cell degranulation, Xolair minimizes the release of mediators throughout the allergic inflammatory cascade.

An injectable prescription medicine, Xolair is approved for the treatment of moderate-to-severe or severe persistent allergic asthma in more than 100 countries, including the US since 2003 and the EU since 2005. Xolair is approved for the treatment of chronic spontaneous urticaria in over 90 countries including the EU and for chronic idiopathic urticaria (CIU), as it is known in the US and Canada. Xolair has over 1.3 million patient years of exposure. In addition, a liquid formulation of Xolair in pre-filled syringes has been approved in the EU and in more than 20 countries outside of the EU, including Canada, the US and Australia. The self-administration indication for Xolair in pre-filled syringes was also approved in the EU in 2018, and has since been approved in several other countries, including Australia, Taiwan, Argentina and Brazil. In the US, Novartis and Genentech, Inc. work together to develop and co-promote Xolair. Outside of the US, Novartis markets Xolair and records all sales and related costs.

For chronic rhinosinusitis with nasal polyps (CRSwNP), Xolair is indicated in the EU as an add-on therapy with intranasal corticosteroids (INC) for the treatment of adults (18 years and above) with severe CRSwNP for whom therapy with INC does not provide adequate disease control1.

About Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Chronic rhinosinusitis with nasal polyps (CRSwNP) impacts up to 4% of people worldwide. It is a potentially debilitating condition in adults that is characterized by inflammation of the nose and paranasal sinuses with the presence of benign inflammatory polyps (nasal polyps) on the lining of the nasal sinuses or nasal cavity, which can block normal airflow2-4. It is possible to have a single polyp or several, and the size of the polyps can vary from microscopic to several centimeters6,7.

Symptoms can include nasal blockage/obstruction, nasal congestion, nasal discharge, facial pain/pressure and reduction in, or loss of, sense of smell2,3. CRSwNP is diagnosed by a physical examination with endoscopy. The condition can be associated with asthma, cystic fibrosis and aspirin sensitivity8. It is also associated with significant morbidity and decreased health-related quality of life, with quality of life impairment9-14. Patients with CRSwNP experience significantly lower health-related quality of life than the general population, with a greater impact for patients with more severe disease, other conditions (comorbidities) or whose CRSwNP has not responded to treatment (refractory disease)12.

Currently, after standard of care intranasal corticosteroids (INC), surgery and systemic corticosteroids are the main treatments for this disease all over the world. Many patients choose them; however, they are often not effective in controlling chronic symptoms over time, due to nasal polyp regrowth. After sinus surgery, nasal polyps recur in up to 80% of people, with approximately 40% requiring at least one additional surgery9. Approximately 80% of people remain uncontrolled 3-5 years after sinus surgery15.

Disclaimer This media update contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as 'potential,' 'can,' 'will,' 'plan,' 'may,' 'could,' 'would,' 'expect,' 'anticipate,' 'seek,' 'look forward,' 'believe,' 'committed,' 'investigational,' 'pipeline,' 'launch,' or similar terms, or by express or implied discussions regarding potential marketing approvals, new indications or labeling for the investigational or approved products described in this media update, or regarding potential future revenues from such products. You should not place undue reliance on these statements. Such forward-looking statements are based on our current beliefs and expectations regarding future events, and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. There can be no guarantee that the investigational or approved products described in this media update will be submitted or approved for sale or for any additional indications or labeling in any market, or at any particular time. Nor can there be any guarantee that such products will be commercially successful in the future. In particular, our expectations regarding such products could be affected by, among other things, the uncertainties inherent in research and development, including clinical trial results and additional analysis of existing clinical data; regulatory actions or delays or government regulation generally; global trends toward health care cost containment, including government, payor and general public pricing and reimbursement pressures and requirements for increased pricing transparency; our ability to obtain or maintain proprietary intellectual property protection; the particular prescribing preferences of physicians and patients; general political, economic and business conditions, including the effects of and efforts to mitigate pandemic diseases such as COVID-19; safety, quality, data integrity or manufacturing issues; potential or actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this media update as of this date and does not undertake any obligation to update any forward-looking statements contained in this media update as a result of new information, future events or otherwise.

About Novartis Novartis is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 109,000 people of more than 140 nationalities work at Novartis around the world. Find out more at https://www.novartis.com.

Novartis is on Twitter. Sign up to follow @Novartis at https://twitter.com/novartisnews For Novartis multimedia content, please visit https://www.novartis.com/news/media-library For questions about the site or required registration, please contact [email protected]

References 1. Xolair (omalizumab). SmPC 2. Stevens WW, Schleimer RP, Kern RC. Chronic Rhinosinusitis with Nasal Polyps. J Allergy Clin Immunol Pract 2016;4(4):565-572. 3. Newton JR and Ah-See KW. A review of nasal polyposis. Ther Clin Risk Manag 2008;4(2):507-512. 4. Bachert C. Evidence-based management of nasal polyposis by intranasal corticosteroids: from the cause to the clinic. Int Arch Allergy Immunol 2011;155(4):309-321. 5. Gevaert P, Omachi TA, Corren J, et al. Efficacy and safety of omalizumab in nasal polyposis: two randomized phase III trials. J Allergy and Clin Immunol 2020. doi.org/10.1016/j.jaci.2020.05.032 [online ahead of print]. 6. Patient. Nasal Polyps [online] February 24, 2017. Available from: https://patient.info/ears-nose-throat-mouth/nasal-polyps-leaflet [Last accessed: August 2020]. 7. Johns Hopkins Medicine. Could nasal polyps be the cause of your stuffy nose? Available from: https://www.hopkinsmedicine.org/health/articles-and-answers/ask-the-expert/stuffy-nose-nasal-polyps [Last accessed: August 2020]. 8. World Allergy Organization. Nasal Polyposis: A Multifactorial disease. Available from: https://www.worldallergy.org/educational_programs/world_allergy_forum/sydney/pawankar.php [Last accessed: August 2020]. 9. Bachert C, Zhang L, Gevaert P. Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis. J Allergy Clin Immunol 2015;136(6):1431-1440. 10. Erskine S, Hopkins C, Kumar N, et al. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes. Rhinology 2016;54(4):311-315. 11. Hoehle LP, Phillips KM, Bergmark RW, et al. Symptoms of chronic rhinosinusitis differentially impact general health-related quality of life. Rhinology 2016;54(4):316-322. 12. Khan A, Huynh TMT, Vandeplas G, et al. The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life. Rhinology 2019;57(5):343-351. 13. Naclerio R, Baroody F, Bachert C, et al. Clinical research needs for the management of chronic rhinosinusitis with nasal polyps in the new era of biologics. A National Institute of Allergy and Infectious Diseases workshop. J Allergy Clin Immunol Pract 2020;8(5):1532-1549.e1. 14. Ye Z, Sun L, Wang Q. A head-to-head comparison of EQ-5D-5 L and SF-6D in Chinese patients with low back pain. Health Qual Life Outcomes 2019;17(1):57. 15. van der Veen J, Seys SF, Timmermans M, et al. Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre. Allergy 2017;72(2):282-290.

# # #

Novartis Media Relations E-mail: [email protected]

Novartis Investor Relations Central investor relations line: +41 61 324 7944 E-mail: [email protected]

Continue reading here:
Novartis : receives EC approval for new Xolair indication to treat severe chronic rhinosinusitis with nasal polyps - Marketscreener.com

Read the Rest...

Healthcare Nanotechnology (Nanomedicine) Market 2020 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies and…

§ August 12th, 2020 § Filed under Nano Medicine Comments Off on Healthcare Nanotechnology (Nanomedicine) Market 2020 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies and…

New Jersey, United States,- The most recent Healthcare Nanotechnology (Nanomedicine) Market Research study includes some significant activities of the current market size for the worldwide Healthcare Nanotechnology (Nanomedicine) market. It presents a point by point analysis dependent on the exhaustive research of the market elements like market size, development situation, potential opportunities, and operation landscape and trend analysis. This report centers around the Healthcare Nanotechnology (Nanomedicine) business status, presents volume and worth, key market, product type, consumers, regions, and key players.

The COVID-19 pandemic has disrupted lives and is challenging the business landscape globally. Pre and Post COVID-19 market outlook is covered in this report. This is the most recent report, covering the current economic situation after the COVID-19 outbreak.

Key highlights from COVID-19 impact analysis:

Unveiling a brief about the Healthcare Nanotechnology (Nanomedicine) market competitive scope:

The report includes pivotal details about the manufactured products, and in-depth company profile, remuneration, and other production patterns.

The research study encompasses information pertaining to the market share that every company holds, in tandem with the price pattern graph and the gross margins.

Healthcare Nanotechnology (Nanomedicine) Market, By Type

Healthcare Nanotechnology (Nanomedicine) Market, By Application

Other important inclusions in the Healthcare Nanotechnology (Nanomedicine) market report:

A brief overview of the regional landscape:

Reasons To Buy:

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Packaging Robot Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Packtech Textiles Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Paclitaxel-eluting Stent Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Paint Pigments Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Paintball Gun Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Originally posted here:
Healthcare Nanotechnology (Nanomedicine) Market 2020 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies and...

Read the Rest...

« Older Entries



Page 11234..1020..»